Implicit Bioscience
Advertisement
Implicit Bioscience, located in Woolloongabba, Queensland, is a pioneering company focused on transforming immunotherapy with its lead therapeutic candidate, IC14, an investigational anti-CD14 monoclonal antibody. The company aims to regulate inflammatory responses to infections and injuries, particularly targeting conditions like motor neurone disease and acute respiratory distress syndrome.
With a team of world leaders in medical research and clinical practice, Implicit Bioscience is currently involved in notable clinical trials, including studies on heart failure and COVID-19. Their innovative approach seeks to address chronic diseases resulting from inappropriate inflammation, positioning them at the forefront of new therapeutic developments in immunology.
Generated from the website
Also at this address
You might also like
Advertisement